From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. Clinical Practice Guideline Watch

HIV/AIDS Clinical Care: Clinical Practice Guideline Watch

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.


to
Items 1-10 of 45 are shown

Updated DHHS Pediatric Antiretroviral Treatment Guidelines

ART should now be considered for all children, regardless of immunologic or clinical status. The strength of the recommendation varies by age and CD4-cell count/percentage.

DHHS Guidelines Add Tenofovir/FTC/Elvitegravir/Cobicistat as an Alternative Regimen for First-Line HIV Treatment

Tenofovir/FTC/elvitegravir/cobicistat is the first single-tablet antiretroviral regimen that includes an HIV integrase inhibitor rather than targeting reverse transcriptase alone.

Interim Guidelines for Using PrEP in Heterosexuals

Recommendations are similar to those for men who have sex with men but include frequent pregnancy tests for women.

Revised DHHS Guidelines for Perinatal Antiretroviral Use

The new guidelines offer more treatment options for pregnant HIV-infected women and explore the range of options available for safe conception in HIV-serodiscordant couples.

New IAS–USA Guidelines Confirm Commitment to Universal HIV Treatment

Benefits are assumed to outweigh risks at all stages of HIV infection.

Updated DHHS Guidelines on HIV Treatment

Key revisions focus on HIV treatment for all, HIV management in older patients, the coadministration of new hepatitis C drugs with antiretrovirals, and the timing of ART initiation in patients with tuberculosis.

Revised HIV Treatment Guidelines from the DHHS

This revision focuses on treatment choices for antiretroviral-naive patients.

Updated Guidelines for Perinatal Antiretroviral Use

The revision includes several new clinical recommendations, as well as a provocative discussion on when to start antiretrovirals in pregnant women who do not require treatment for their own health.

DHHS Lists Rilpivirine as an Alternative NNRTI

Efavirenz is still the only preferred nonnucleoside reverse transcriptase inhibitor for initial treatment regimens.

Interim CDC Guidance on Pre-Exposure Prophylaxis for HIV Prevention in MSM

In the wake of the iPrEx study, the CDC offers some general guiding principles for the implementation of pre-exposure prophylaxis.

Items 1-10 of 45 are shown

to

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.